Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study - Concepedia

Concepedia

Publication | Closed Access

Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study

16

Citations

19

References

2008

Year

Oliver Schöffski, Lusine Breitscheidel, Ursula Benter, Franz‐Werner Dippel, Markus Müller, Michael Volk, Martin Pfohl

Journal of Medical Economics

Abstract

The LIVE-SPP study suggests that insulin glargine-based therapies may offer an economic advantage over NPH-based therapies.

References

	Year	Citations

Page 1